Table 2 Number and percentage of cases according to components of therapy in patients with KD at the NUNH Hospital between the 21st Nationwide survey (2009–10) and the second cohort (high-dose IVIG)
21stNationwide survey (2009–10) | Second cohort (2010–12) | p-value | |||
|---|---|---|---|---|---|
Total | 23,730 | 100.0 | 112 | 100.0 | |
Dosage of IVIG | Cases | % | Cases | % | |
2 g/kg | 17,547 | 74.0 | 85 | 75.9 | 0.75 |
1 g/kg/day × 2 d | 2,803 | 11.8 | 5 | 4.5 | 0.01 |
400 mg/kg/day × 5 d | 20 | 0.08 | 4 | 3.6 | 0.001 |
Various dosages of IVIG | 868 | 3.65 | 0 | 0 | 0.04 |
Aspirin alone (no IVIG) | 2,492 | 10.5 | 18 | 16.1 | 0.06 |
Dalteparin | 0 | 0 | 112 | 100.0 | |
Age (months) | -* | 19 (0–66) | |||
Male sex | 13,515 (57.0%) | 59 (52.7%) | 0.39 | ||